Southern California Record

Wednesday, September 18, 2019

Schiff Hardin LLP

Recent News About Schiff Hardin LLP View More

  • SCHIFF HARDIN: Aly Joins Center for Biosimilars Advisory Board

    Intellectual Property Practice Group Co-Leader Imron Aly has joined the advisory board for the Center for Biosimilars, an online resource for emerging pharmaceutical biotechnology that discusses the current landscape for advanced health care management with top industry thought leaders.